Veterinary Medicines

GALLIVAC IBD

Authorised
  • Infectious bursal disease virus, strain S706, Live
Download as PDF

Product identification

Medicine name:
GALLIVAC IBD
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    199526.00
    cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 1000 doses. Cartons containing 1 vial of 1000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2000 doses. Cartons containing 1 vial of 2000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2500 doses. Cartons containing 1 vial of 2,500 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 5000 doses. Cartons containing 1 vial of 5,000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 1000 doses. Cartons containing 10 vials of 1000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2000 doses. Cartons containing 10 vials of 2000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2500 doses. Cartons containing 10 vials of 2,500 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 5000 doses. Cartons containing 10 vials of 5,000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 1000 doses. Cartons containing 50 vials of 1000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2000 doses. Cartons containing 50 vials of 2000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2500 doses. Cartons containing 50 vials of 2,500 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 5000 doses. Cartons containing 50 vials of 5,000 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/057/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."